1.85% 0.21

Rocket Pharmaceuticals Inc (RCKT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Rocket Pharmaceuticals Inc Azioni (RCKT) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	6.47% 67.38	63.28	65.43	68.76	62.19
Interest Income/Expense	0.21% 0.471	0.47	0.469	0.468	0.468
Operating Income/Loss	6.47% -67.38	-63.28	-65.43	-68.76	-62.19
Income/Loss From Continuing Operations Before Tax	4.01% -62.05	-59.66	-61.90	-65.70	-58.34
Income/Loss From Continuing Operations After Tax	4.01% -62.05	-59.66	-61.90	-65.70	-58.34
Net Income/Loss	4.01% -62.05	-59.66	-61.90	-65.70	-58.34
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	2,876% 93.55	3.1433	82.64	80.47	79.45
Diluted Average Shares	2,876% 93.55	3.1433	82.64	80.47	79.45
Basic Earnings Per Share	6.45% -0.66	-0.62	-0.75	-0.82	-0.73
Diluted Earnings Per Share	6.45% -0.66	-0.62	-0.75	-0.82	-0.73
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$17.87

2.88%

INCY

$68.84

2.65%

MRNA

$39.39

0.43%

UTHR

$359.58

0.16%

BGNE

$176.50

1.02%

BNTX

$113.08

1.56%